# Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy

> **NCT01348607** · PHASE2 · TERMINATED · sponsor: **University of South Florida** · enrollment: 1 (actual)

## Conditions studied

- Central Nervous System Tumor, Pediatric
- Fatigue
- Specific Disorders of Sleep

## Interventions

- **DRUG:** methylphenidate hydrochloride
- **DRUG:** modafinil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01348607
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study only randomized 1 subject and was determined not feasible by DSMB
- **Last updated:** 2014-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01348607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01348607, "Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01348607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*